Abstract
Radiation therapy is a cornerstone of cancer treatment worldwide. Unfortunately, in many cases, it does not control tumor growth, and many tumors display treatment resistance. The molecular pathways leading to treatment resistance in cancer have been subject to research for many years. Isogenic cell lines with divergent radiosensitivities are an extremely useful tool to study the molecular mechanisms that underpin radioresistance in cancer research, as they reduce the genetic variation that is present in patient samples and cell lines of different origin, thus allowing the elucidation of molecular determinants of radioresponse. Here, we describe the process of generating an in vitro isogenic model of radioresistant esophageal adenocarcinoma by chronic irradiation of esophageal adenocarcinoma cells with clinically relevant doses of X-ray radiation. We also characterize cell cycle, apoptosis, reactive oxygen species (ROS) production, DNA damage and repair in this model to investigate the underlying molecular mechanisms of radioresistance in esophageal adenocarcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Domina EA, Philchenkov A, Dubrovska A (2018) Individual response to ionizing radiation and personalized radiotherapy. Crit Rev Oncog 23(1-2):69–92. https://doi.org/10.1615/CritRevOncog.2018026308
Lynam-Lennon N, Reynolds JV, Pidgeon GP, Lysaght J, Marignol L, Maher SG (2010) Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma. Radiat Res 174(6):703–711. https://doi.org/10.1667/rr2295.1
Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y et al (2004) Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 91(8):1543–1550. https://doi.org/10.1038/sj.bjc.6602187
Wang L, Li S, Zhu X (2020) Construction of radiation surviving/resistant lung cancer cell lines with Equidifferent gradient dose irradiation. Dose-Response 18(4):1559325820982421. https://doi.org/10.1177/1559325820982421
Li Y, Li H, Peng W, He XY, Huang M, Qiu D et al (2015) DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair. Mol Med Rep 12(1):1328–1334. https://doi.org/10.3892/mmr.2015.3505
Gray M, Turnbull AK, Ward C, Meehan J, Martínez-Pérez C, Bonello M et al (2019) Development and characterisation of acquired radioresistant breast cancer cell lines. Radiat Oncol (Lond, Engl) 14(1):64. https://doi.org/10.1186/s13014-019-1268-2
Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K et al (1999) Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer (Oxf, Engl: 1990) 35(9):1374–1380. https://doi.org/10.1016/s0959-8049(99)00134-3
McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S et al (2016) Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep 6:34796. https://doi.org/10.1038/srep34796
Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315–2319. https://doi.org/10.1038/nprot.2006.339
Pawlik TM, Keyomarsi K (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59(4):928–942. https://doi.org/10.1016/j.ijrobp.2004.03.005
Brown JM, Attardi LD (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5(3):231–237. https://doi.org/10.1038/nrc1560
Meyn RE, Stephens LC, Milas L (1996) Programmed cell death and radioresistance. Cancer Metastasis Rev 15(1):119–131. https://doi.org/10.1007/bf00049491
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN et al (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780–783. https://doi.org/10.1038/nature07733
Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ et al (2004) Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 279(3):2273–2280. https://doi.org/10.1074/jbc.M310030200
Kuwahara Y, Li L, Baba T, Nakagawa H, Shimura T, Yamamoto Y et al (2009) Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays. Cancer Sci 100(4):747–752. https://doi.org/10.1111/j.1349-7006.2009.01082.x
Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F (1997) Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27(1):1–20
Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184(1):39–51. https://doi.org/10.1016/0022-1759(95)00072-i
Radford IR (1985) The level of induced DNA double-strand breakage correlates with cell killing after X-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med 48(1):45–54. https://doi.org/10.1080/09553008514551051
Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC et al (2002) DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 4(12):993–997. https://doi.org/10.1038/ncb884
Banáth JP, Klokov D, MacPhail SH, Banuelos CA, Olive PL (2010) Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer 10:4. https://doi.org/10.1186/1471-2407-10-4
Acknowledgments
A.C. and N.L.L. are supported by the Health Research Board, grant numbers ILP-POR-2017-007 and EIA-2017-020.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Cannon, A., Maher, S.G., Lynam-Lennon, N. (2023). Generation and Characterization of an Isogenic Cell Line Model of Radioresistant Esophageal Adenocarcinoma. In: Movia, D., Prina-Mello, A. (eds) Cancer Cell Culture. Methods in Molecular Biology, vol 2645. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3056-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3056-3_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3055-6
Online ISBN: 978-1-0716-3056-3
eBook Packages: Springer Protocols